TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive Also in this 8-page issue: Cooperative groups tell Congress that NCI’s $115 million in support for adult cancer clinical trials is “chump change.” Trials would close faster, report results sooner, if funding were increased, regulatory issues streamlined. May 28, 2004
TCL Archive Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped February 8, 1974
